The Oncotype DX Test should be performed when patients are diagnosed with breast cancer. Dr. Steven Shak explains that the Oncotype DX test helps your doctor determine the best course of treatment for newly diagnosed breast cancer patients.
Steven Shak, MD: The Oncotype DX test should be taken at the time of a new diagnosis of breast cancer or of ductal carcinoma in situ, otherwise known as DCIS.
It is very important to remember that you have time to get the right diagnosis and it can be very frustrating in those days or weeks to wait for all that information you need in order to decide the right treatment for you, but that time is critical and the Oncotype DX test can play a critical role in making sure that you get the right treatment.
Learn More About The Oncotype DX Test Here
Dr. Steven Shak co-founded Genomic Health Inc. and has been its Chief Medical Officer since December 2000. Dr. Shak has been a leader in personalized medicine for more than two decades. Under Dr. Shak’s leadership Genomic Health used innovative molecular diagnostic methods and rigorous clinical studies to develop the Oncotype DX® breast cancer and colon cancer assays and has maintained an 80% product development success rate. Prior to Genomic Health, Dr. Shak served for 14 years in various roles in Discovery Research and Medical Affairs at Genentech, Inc. In addition, Dr. Shak led the clinical team that gained approval for Herceptin®, a pharmacogenomic treatment for metastatic breast cancer. Prior to Genentech, Dr. Shak served as an Assistant Professor of Medicine and Pharmacology at the New York University School of Medicine. Dr. Shak holds a BA in Chemistry from Amherst College and an MD from the New York University School of Medicine, and completed his Post-Doctoral training at the University of California, San Francisco.
This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.